Cargando…

Hydroxychloroquine: Acute kidney injury, prolonged QTC interval and renal phospholipidosis following off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892757/ http://dx.doi.org/10.1007/s40278-021-91291-9

Ejemplares similares

Hydroxychloroquine: Prolonged QTc interval following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc interval prolonged following off label use: case report
Publicado: (2021)

Hydroxychloroquine: Borderline prolongation of QTc interval during off-label treatment: case report
Publicado: (2020)

Hydroxychloroquine: QTc prolongation following off-label-use: case report
Publicado: (2020)

Hydroxychloroquine: QTc-prolongation following an off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Hydroxychloroquine/lopinavir/ritonavir: Vomiting and QTc-interval prolongation following off-label therapy: 2 case reports
Publicado: (2021)

Hydroxychloroquine: Persistent increase in QTc interval following off-label use: case report
Publicado: (2022)

Hydroxychloroquine: Sinus bradycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation following off-label use: 2 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation and off label use: 3 case reports.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation during off-label treatment: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QTc during off label use: case report
Publicado: (2021)

Hydroxychloroquine: Right bundle branch block and QTc prolongation following off label use: case report
Publicado: (2020)

Antivirals/fluoroquinolones: Prolongation of QTc interval following off-label use: 9 case reports
Publicado: (2021)

Multiple drugs: QTc interval prolongation following off-label use: 5 case reports
Publicado: (2022)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

Hydroxychloroquine: Non-sustained monomorphic ventricular tachycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/favipiravir/hydroxychloroquine interactions: Corrected QT (QTc) interval prolongation due to pharmacodynamic interaction following off label use: 2 case reports
Publicado: (2021)

Hydroxychloroquine: QTc prolongation: case report.
Publicado: (2020)

Antibacterials/antivirals: QTc-interval prolongation and cardiac arrest following off-label therapy: 3 case reports
Publicado: (2021)

Chloroquine: QTc prolongation following off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

Hydroxychloroquine: Electrical storm and QT interval prolongation following off-label use: case report
Publicado: (2020)

Curvilinear bodies in hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease
por: Costa, Rui M., et al.
Publicado: (2013)

Hydroxychloroquine: QTc prolongation: 2 case reports
Publicado: (2021)

Chloroquine: QTc interval prolongation leading to frequent extrasystoles and ventricular tachycardia following off label use: case report
Publicado: (2021)

Atazanavir/ritonavir: QTc prolongation following off-label treatment: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

Multiple drugs: Atrial fibrillation, Bradycardia, QTC interval prolongation and off label use: 2 case reports
Publicado: (2021)

Multiple drugs: Off label use and QTc prolongation: case report
Publicado: (2021)

Multiple drugs: QTc prolongation and off-label use: case report
Publicado: (2021)

Chloroquine/lopinavir/ritonavir/umifenovir: QTc interval prolongation, drug interaction and off-label use: 2 case reports
Publicado: (2020)

Chloroquine/dalteparin sodium/hydroxycarbamide: Prolongation of the QTc interval secondary to off-label use and lack of efficacy: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k0d80j7mmu3n2g4hd0mskisfc9